chemotherapy protocol consisting of hypoxanthine, thymidine, and an antifolate such as aminopterin; hypoxanthine and thymidine protect non-mutating cells from antifolate agent (e.g. aminopterin); mutant cells unable to utilize hypoxanthine; used as antineoplastic agent and culture media supplement
